Search

Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More

BIO ROUNDUP: $74B FOR CELGENE, TWO CAR-T TALES, READY FOR SF & MORE

In 2018, my Exome colleagues and I published hundreds of stories about health, medicine, the biopharma industry, government policy,...

 
 
 

VERACYTE ANNOUNCES PIVOTAL CLINICAL VALIDATION DATA FOR AFIRMA GENOMIC SEQUENCING CLASSIFIER PRESENTED AT

Life Sciences Jobs ...